Nokwe, C.N.* ; Hora, M. ; Zacharias, M.* ; Yagi, H.* ; Peschek, J.* ; Reif, B. ; Goto, Y.* ; Buchner, J.*
A stable mutant predisposes antibody domains to amyloid formation through specific non-native interactions.
J. Mol. Biol. 428, 1315-1332 (2016)
The aggregation of mostly antibody light chain variable (VL) domains into amyloid fibrils in various tissues is the main cause of death in systemic amyloid light chain amyloidosis. Point mutations within the domain are important to shift the VL into the fibrillar pathway. But why and how only some site-specific mutations achieve this still remains elusive. We show here that both destabilizing and surprisingly stable mutants readily predispose an amyloid resistant VL domain to amyloid formation. The decreased thermodynamic stability of the destabilizing mutant results in the accumulation of non-native intermediates that readily populate the amyloid state. Interestingly, the stable mutants establish site-specific non-native interactions with especially nearby serine/threonine residues that unexpectedly do not affect the folding behavior of the VL domain but rather readily induce and stabilize the fibril structure, a previously unrecognized mechanism. These findings provide a new concept for the molecular mechanism of amyloid fibril formation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Immunoglobulin Fold ; Antibody Amyloid ; Domain Stability ; Point Mutations ; Protein Folding And Aggregation Disease; Immunoglobulin Light-chains; Bence-jones Proteins; Fibril Formation; Deposition Disease; Molten Globule; Systemic Amyloidoses; Crystal-structure; Variable Domains; Peptide Gnnqqny; Folding Pathway
Keywords plus
Language
Publication Year
2016
Prepublished in Year
HGF-reported in Year
2016
ISSN (print) / ISBN
0022-2836
e-ISSN
1089-8638
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 428,
Issue: 6,
Pages: 1315-1332
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503090-001
Grants
Copyright
Erfassungsdatum
2016-02-03